References for Volume I of Tobias and Johnston: Veterinary Surgery: Small Animal, ed


Chapter 2: Molecular and Cellular Biology: Genomics



Yüklə 3,38 Mb.
səhifə2/74
tarix02.01.2022
ölçüsü3,38 Mb.
#2286
1   2   3   4   5   6   7   8   9   ...   74
Chapter 2: Molecular and Cellular Biology: Genomics



REFERENCES

  1. Argyle DJ: Telomerase: a missing link between ageing, cancer and novel therapies? Vet J 175:149, 2008. PUBMED Abstract

  2. Barrett JG, Hao Z, Graf BK, et al: Inflammatory changes in ruptured canine cranial and human anterior cruciate ligaments. Am J Vet Res 66:2073, 2005. PUBMED Abstract

  3. Belle A, Tanay A, Bitincka L, et al: Quantification of protein half-lives in the budding yeast proteome. PNAS 103:13004, 2006. PUBMED Abstract

  4. Birmingham A, Anderson EM, Reynolds A, et al: 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3:199, 2006. PUBMED Abstract

  5. Black LL, Gaynor J, Adams C, et al: Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9:192, 2008. PUBMED Abstract

  6. Black LL, Gaynor J, Gahring D, et al: Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther 8:272, 2007. PUBMED Abstract

  7. Boggs R, Wright Z, Stickney M, et al: MicroRNA expression in canine mammary cancer. Mamm Genome 19:561, 2008. PUBMED Abstract

  8. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33(suppl):228, 2003. PUBMED Abstract

  9. Burgener IA, Kovacevic A, Mauldin GN, et al: Cardiac troponins as indicators of acute myocardial damage in dogs. J Vet Intern Med 20:277, 2006. PUBMED Abstract

  10. Burton-Wurster N, Mateescu RG, Todhunter RJ, et al: Genes in canine articular cartilage that respond to mechanical injury: gene expression studies with Affymetrix Canine GeneChip. J Hered 97:821, 2005. PUBMED Abstract

  11. Campbell SE, Bennett D, Nasir L, et al: Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model. Rheumatology 44:735, 2005. PUBMED Abstract

  12. Campbell SE, Nasir L, Gault EA, et al: Preliminary studies of particle-mediated gene delivery to the joints of dogs. Vet Rec 160:476, 2007. PUBMED Abstract

  13. Castrillo J, Zeef L, Hoyle D, et al: Growth control of the eukaryote cell: a systems biology study in yeast. J Biol 6:4, 2007. PUBMED Abstract

  14. Chase K, Lawler DF, Carrier DR, et al: Genetic regulation of osteoarthritis: a QTL regulating cranial and caudal acetabular osteophyte formation in the hip joint of the dog (canis familiaris). Am J Med Genet 135:334, 2005. PUBMED Abstract

  15. Clements DN, Carter SD, Innes JF, et al: Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative-PCR. Arthritis Res Ther 8:R158, 2006. PUBMED Abstract

  16. Clements DN, Carter SD, Innes JF, et al: Gene expression profiling of normal and ruptured canine anterior cruciate ligaments. Osteoarthritis Cartilage 16:195, 2008. PUBMED Abstract

  17. Credille KM, Minor JS, Barnhart KF, et al: Transglutaminase 1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs. Br J Dermatol 161:265, 2009. PUBMED Abstract

  18. Cucchiarini M, Thurn T, Weimer A, et al: Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56:158, 2007. PUBMED Abstract

  19. da Silva MA, Yamada N, Clarke NM, et al: Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res 27:593, 2009. PUBMED Abstract

  20. DeBaise P, Capanna R: Clinical applications of BMPs. Injury 36(suppl 3):S43, 2005. PUBMED Abstract

  21. Draisma G, Boer R, Otto SJ, et al: Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95:868, 2003. PUBMED Abstract

  22. Emerson MV, Lauer AK: Current and emerging therapies for the treatment of age-related macular degeneration. Clin Ophthalmol 2:377, 2008. PUBMED Abstract

  23. Feldmann M, Maini RN: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9:1245, 2003. PUBMED Abstract

  24. Fleischer S, Sharkey M, Mealey K, et al: Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model. AAPS J 10:110, 2008. PUBMED Abstract

  25. Fox S, Filichkin S, Mockler TC: Applications of ultra-high-throughput sequencing. Methods Mol Biol 553:79, 2009. PUBMED Abstract

  26. Freilich S, Massingham T, Bhattacharyya S, et al: Relationship between the tissue-specificity of mouse gene expression and the evolutionary origin and function of the proteins. Genome Biol 6:R56, 2005. PUBMED Abstract

  27. Games D, Adams D, Alessandrini R, et al: Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523, 1995. PUBMED Abstract

  28. Garcia DE, Baidoo EE, Benke PI, et al: Separation and mass spectrometry in microbial metabolomics. Curr Opin Microbiol 11:233, 2008. PUBMED Abstract

  29. Gaspar HB, Parsley KL, Howe S, et al: Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364:2181, 2004. PUBMED Abstract

  30. Hanna J, Wernig M, Markoulaki S, et al: Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920, 2007. PUBMED Abstract

  31. Hannenhalli SS, Middleton RP, Levy S, et al: Identification and cross-species comparison of canine osteoarthritic gene regulatory cis-elements. Osteoarthritis Cartilage 14:830, 2006. PUBMED Abstract

  32. Hirschhorn JN, Lohmueller K, Byrne E, et al: A comprehensive review of genetic association studies. Gen Med 4:45, 2002. PUBMED Abstract

  33. Hsu WL, Huang HM, Liao JW, et al: Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. Vet J 180:116, 2009. PUBMED Abstract

  34. Karlsson EK, Lindblad-Toh K: Leader of the pack: gene mapping in dogs and other model organisms. Nat Rev Genet 9:713, 2008. PUBMED Abstract

  35. Kirkness EF, Bafna V, Halpern AL, et al: The dog genome: survey sequencing and comparative analysis. Science 301:1898, 2003. PUBMED Abstract

  36. Kotzsch M, Sieuwerts A, Grosser M, et al: Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Res Treat 111:229, 2008. PUBMED Abstract

  37. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. J Am Med Assoc 279:1200, 1998.

  38. Lemburg AK, Meyer-Lindenberg A, Hewicker-Trautwein M: Immunohistochemical characterization of inflammatory cell populations and adhesion molecule expression in synovial membranes from dogs with spontaneous cranial cruciate ligament rupture. Vet Immunol Immunopathol 97:231, 2004. PUBMED Abstract

  39. Lindblad-Toh K, Wade CM, Mikkelsen TS, et al: Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803, 2005. PUBMED Abstract

  40. Lund JR, Paoloni M, Kurzman I, et al: Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies. Vet J 177:192, 2008. PUBMED Abstract

  41. Lyon MF: Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135, 1962. PUBMED Abstract

  42. Marguerat S, Wilhelm BT, Bähler J: Next-generation sequencing: applications beyond genomes. Biochem Soc Trans 36:1091, 2008. PUBMED Abstract

  43. Marschall Y, Distl O: Mapping quantitative trait loci for canine hip dysplasia in German Shepherd dogs. Mamm Genome 18:861, 2007. PUBMED Abstract

  44. Mateescu RG, Burton-Wurster NI, Tsai K, et al: Identification of quantitative trait loci for osteoarthritis of hip joints in dogs. Am J Vet Res 69:1294, 2008. PUBMED Abstract

  45. McCaw DL, Chan AS, Stegner AL, et al: Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clin Cancer Res 13:2496, 2007. PUBMED Abstract

  46. Mealey KL, Bentjen SA, Gay JM, et al: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenet Genomics 11:727, 2001. PUBMED Abstract

  47. Millanta F, Calandrella M, Citi S, et al: Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential. Vet Pathol 42:30, 2005. PUBMED Abstract

  48. Mohammadi M, Day PJR: Oligonucleotides used as template calibrators for general application in quantitative polymerase chain reaction. Anal Biochem 335:299, 2004. PUBMED Abstract

  49. Morgan RA, Dudley ME, Wunderlich JR, et al: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314:126, 2006. PUBMED Abstract

  50. Muir P, Oldenhoff WE, Hudson AP, et al: Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog 42:47, 2007. PUBMED Abstract

  51. Patterson EE, Minor KM, Tchernatynskaia AV, et al: A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse. Nat Genet 40:1235, 2008. PUBMED Abstract

  52. Paulson SK, Engel L, Reitz B, et al: Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos 27:1133, 1999. PUBMED Abstract

  53. Pele M, Tiret L, Kessler JL, et al: SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet 14:1417, 2005. PUBMED Abstract

  54. Pelham JT, Irwin PJ, Kay PH: Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders. Res Vet Sci 74:101, 2003. PUBMED Abstract

  55. Pontius JU, Mullikin JC, Smith DR, et al: Initial sequence and comparative analysis of the cat genome. Genome Res 17:1675, 2007. PUBMED Abstract

  56. Pontius JU, O’Brien SJ: Genome annotation resource fields (GARFIELD): a genome browser for Felis catus. J Hered 98:386, 2007. PUBMED Abstract

  57. Randolph JE, Scarlett J, Stokol T, et al: Clinical efficacy and safety of recombinant canine erythropoietin in dogs with anemia of chronic renal failure and dogs with recombinant human erythropoietin-induced red cell aplasia. J Vet Intern Med 18:81, 2004. PUBMED Abstract

  58. Rans TS, England R: The evolution of gene therapy in X-linked severe combined immunodeficiency. Ann Allergy Asthma Immunol 102:357, 2009. PUBMED Abstract

  59. Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971, 2006. PUBMED Abstract

  60. Riley JH, Allan CJ, Lai E, et al: The use of single nucleotide polymorphisms in the isolation of common disease genes. Pharmacogenomics 1:39, 2000. PUBMED Abstract

  61. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 273:1516, 1996. PUBMED Abstract

  62. Rogers S, Girolami M, Kolch W, et al: Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models. Bioinformatics 24:2894, 2008. PUBMED Abstract

  63. Ross JS, Fletcher JA, Linette GP, et al: The HER-2/neu gene and protein in breast cancer: biomarker and target of therapy. Oncologist 8:307, 2003. PUBMED Abstract

  64. Salmon Hillbertz NHC, Isaksson M, Karlsson EK, et al: Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs. Nat Genet 39:1318, 2007. PUBMED Abstract

  65. Santangelo AM, de Souza FSJ, Franchini LF, et al: Ancient exaptation of a CORE-SINE retroposon into a highly conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PLoS Genet 3:e166, 2007. PUBMED Abstract

  66. Sargan DR, Aguirre-Hernandez J, Galibert F, et al: An extended microsatellite set for linkage mapping in the domestic dog. J Hered 98:221, 2007. PUBMED Abstract

  67. Schmoekel HG, Weber FE, Hurter K, et al: Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. J Small Anim Pract 46:17, 2005. PUBMED Abstract

  68. Schmokel HG, Weber FE, Seiler G, et al: Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg 33:112, 2004. PUBMED Abstract

  69. Schober KE, Cornand C, Kirbach B, et al: Serum cardiac troponin I and cardiac troponin T concentrations in dogs with gastric dilatation-volvulus. J Am Vet Med Assoc 221:381, 2002. PUBMED Abstract

  70. Schroder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320, 2009. PUBMED Abstract

  71. Scott SW: Genetics of primary generalized osteoarthritis. Mol Genet Metab 77:31, 2002. PUBMED Abstract

  72. Shen J, Samul R, Silva RL, et al: Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 13:225, 2005.

  73. Shendure J, Ji H: Next-generation DNA sequencing. Nat Biotechnol 26:1135, 2008. PUBMED Abstract

  74. Sleeper MM, Bish LT, Sweeney HL: Gene therapy in large animal models of human cardiovascular genetic disease. ILAR J 50:199, 2009. PUBMED Abstract

  75. Stanton H, Rogerson FM, East CJ, et al: ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434:648, 2005. PUBMED Abstract

  76. Stephens TD, Bunde CJW, Fillmore BJ: Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol 59:1489, 2000. PUBMED Abstract

  77. Stieger K, Lheriteau E, Moullier P, et al: AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J 50:206, 2009. PUBMED Abstract

  78. Stoker A, Cook J, Kuroki K, et al: Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs. J Orthop Surg Res 1:8, 2006. PUBMED Abstract

  79. Sutter NB, Eberle MA, Parker HG, et al: Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 14:2388, 2004. PUBMED Abstract

  80. Tabar MD, Roura X, Francino O, et al: Detection of Leishmania infantum by real-time PCR in a canine blood bank. J Small Anim Pract 49:325, 2008. PUBMED Abstract

  81. Tanzer A, Stadler PF: Molecular evolution of a microRNA cluster. J Mol Biol 339:327, 2004. PUBMED Abstract

  82. Todhunter R, Mateescu R, Lust G, et al: Quantitative trait loci for hip dysplasia in a crossbreed canine pedigree. Mamm Genome 16:720, 2005. PUBMED Abstract

  83. Um SY, Chung MW, Kim KB, et al: Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats. Anal Chem 81:4734, 2009. PUBMED Abstract

  84. Vandesompele J, De Preter K, Pattyn F, et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:0034.1, 2002. PUBMED Abstract

  85. VanGuilder HD, Vrana KE, Freeman WM: Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44:619, 2008. PUBMED Abstract

  86. Wang Z, Chamberlain JS, Tapscott SJ, et al: Gene therapy in large animal models of muscular dystrophy. Institute of Laboratory Animal Resources Journal 50:187, 2009. PUBMED Abstract

  87. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57, 2009. PUBMED Abstract

  88. Watson JD, Crick FJ: Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171:737, 1953. PUBMED Abstract

  89. Watson JD, Jordan E: The human genome program at the National Institutes of Health. Genomics 5:654, 1989. PUBMED Abstract

  90. Whitfield P, Noble PJ, Major H, et al: Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 1:215, 2005.

  91. Wilkins MR, Sanchez JC, Gooley AA, et al: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13:19, 1996. PUBMED Abstract

  92. Wilkinson LS, Davies W, Isles AR: Genomic imprinting effects on brain development and function. Nat Rev Neurosci 8:832, 2007. PUBMED Abstract

  93. Wilson CR, Regnier FE, Knapp DW, et al: Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma. Vet Comp Oncol 6:171, 2008. PUBMED Abstract

  94. Ye L, Chang JC, Lin C, et al: Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. PNAS 106:9826, 2009. PUBMED Abstract

  95. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917, 2007. PUBMED Abstract


Yüklə 3,38 Mb.

Dostları ilə paylaş:
1   2   3   4   5   6   7   8   9   ...   74




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin